Search results
Showing 8001 to 8050 of 8118 results
Use NICE quality standards to guide good quality social care, says CQC
Social care services should use NICE guidance and quality standards to help identify and define good quality care, according to the Care Quality Commission (CQC).
Use paracetamol to relieve a sore throat rather than antibiotics
The majority of sore throats do not need antibiotics and medicated lozenges may only help to reduce pain by a small amount, NICE says.
In the bag - making moving between hospital and social care better
The introduction of a 'red bag' Hospital Transfer Pathway has helped to improve and speed up the transfer between hospital and care home settings.
NICE and the MHRA have been awarded £1.8m funding by Wellcome over three years to explore and produce guidance on regulating digital mental health tools.
Wireless device recommended for treating people with overactive bladder
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended relugolix with estradiol and norethisterone acetate (also called Ryeqo and made by Gedeon Ritcher UK) in final draft guidance.
A new approach to prioritising requests for NICE Scientific Advice
Dr Jacoline Bouvy explains the new NICE Scientific Advice prioritisation process.
For the last three years, NICE has been part of a research project investigating how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health
A 'safe space' for addressing complex health technology assessment challenges
Nick Crabb discusses how we’re developing a collaborative space for research and development, to help us create new methods and processes for health technology assessment.
People growing older with learning disabilities should get regular health checks, says NICE
NICE says people growing older with learning disabilities need to have annual health checks to help them manage conditions that can quickly affect them as they grow older.
People with advanced or metastatic urothelial cancer to get life-extending treatment
Around 130 people per year with untreated locally advanced or metastatic urothelial cancer will be eligible for a new life-extending treatment after NICE published final draft guidance today (30 September 2021) recommending atezolizumab.
Place young people moving into adult services at the heart of decisions about care
Young people who are moving from children’s to adults’ services should be placed at the heart of decisions about their care, NICE says.
Poor discharge practice leading to 'unnecessary patient suffering'
Poor hospital discharge practice is leading to unnecessary patient suffering and millions in wasted resources, according to a new report.
Positive healthcare experience for babies, children and young people essential to their wellbeing
New guideline from NICE recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare.
Pregnant women to be offered first test to help diagnose pre-eclampsia
Midwives caring for pregnant women can use one of four blood tests to help diagnose suspected preterm pre-eclampsia, NICE has said in new draft diagnostic guidance.
Price discount helps give green light for breast cancer drug pertuzumab
NICE approves the third breast cancer drug is as many weeks as pertuzumab is recommended to shrink tumours in some people with breast cancer so surgery can take place.
Procedure carried out on unborn babies with spina bifida could improve their neurodevelopment
Operations are set to start taking place in the NHS
Professor Leng has spent more than 20 years working at NICE
Prompt diagnosis of social anxiety disorder leads to effective treatment
A prompt diagnosis of social anxiety disorder is crucial in ensuring people access the most clinical and cost effective treatment, according to NICE.
Recruitment begins to fill up to seven non-executive roles on the NICE board
Roles will contribute to the development of NICE’s strategic objectives
The Health Technology Assessment International (HTAi) 2021 Annual Meeting will be held virtually from 19-23 June 2021, and registration is now open.
Rehabilitation after traumatic injury should support people in resuming their lives
NICE has today (27 July 2021) published a new draft guideline covering rehabilitation after traumatic injury.
Remove earwax if a build-up is causing hearing loss problems, NICE tells primary care
GP surgeries or community clinics should offer to remove earwax if a build-up is contributing to someone’s hearing loss.
NICE launches The Office for Market Access to work with industry to speed up the adoption of new medicines, devices and diagnostics by the NHS.
The 20th cancer treatment to go through the Cancer Drugs Fund following a period of managed access has been recommended for routine use in the NHS by NICE in final draft guidance published today (24 February).
Ovarian cancer patients to have NICE-approved drug combination option on Cancer Drugs Fund
A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be available on the Cancer Drugs Fund (CDF), following its approval by NICE in draft guidance published today.
An innovative life-extending drug for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults is being recommended by NICE as an option for use within the Cancer Drugs Fund.
Over 600 people set to benefit from innovative lung cancer treatment within the Cancer Drugs Fund
More than 600 people could benefit from an innovative drug for a form of lung cancer as NICE publishes final draft guidance recommending osimertinib within the Cancer Drugs Fund.
New potentially life-extending lung cancer drug which targets a specific genetic mutation recommended by NICE
Taking medicines such as painkillers over a prolonged period of time to relieve headaches can actually make symptoms worse, according to latest guidelines from NICE.
Patients should be more involved in decisions about their care, says NICE
A new collaborative, made up of the UK’s leading health care organisations including NICE, has set out plans that will help get patients more involved in decisions about their care.
Patients with blood clots should be treated within 4 hours, says NICE
People who present to hospital with blood clots in the legs or lungs should be offered treatment within 4 hours and have their investigative tests including scans within 24 hours, according to latest guidelines.
Patients with rare bile duct cancer set to benefit from life extending treatment
Some people who have a rare form of bile duct cancer are set to benefit from life-extending treatment
Patients with rare blood disorders to receive new treatment option, says NICE
Hundreds of people with two rare blood disorders will soon have access to a new treatment regimen following guidance from NICE.
Shared decision making is an integral part of healthcare, says NICE
Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft guidance published today.
Shared decision making between service users and healthcare professionals is an integral part of healthcare, says NICE, in new guideline recommendations published today.
Simple blood test for pneumonia can help limit use of antibiotics
Using the C-reactive protein blood test can help GPs determine whether a person with a chest infection has pneumonia and should be treated with antibiotics, NICE says.
Small, practical steps are best way of maintaining a healthy weight
Limiting screen time, walking more, and eating healthily are among the most effective ways of maintaining a healthy weight and preventing excess weight gain.
South Tyneside wins first NICE Local Government Chronicle Public Health Award
South Tyneside Metropolitan Borough Council (MBC) has been named the winner of the first Local Government Chronicle (LGC) Public Health Award sponsored by NICE.
New evidence on the safety of statins means more people could benefit from them, new NICE draft guidance says.
Statins should be offered to everyone who has chronic kidney disease, says NICE
Healthcare professionals should offer statins to millions of people with chronic kidney disease (CKD). This will help to manage their increased risk of cardiovascular disease (CVD), says NICE.
Researchers wanted to study the public's views of health-related quality of life
Applications close on Wednesday 4 March 2020
Updated NICE guidance will help to safeguard NHS staff and patients by preventing violent situations and offering clear advice on managing them safely if needed.
Selective laser therapy recommended to treat glaucoma and ocular hypertension
People newly diagnosed with glaucoma and ocular hypertension (OHT) should initially be offered selective laser therapy (SLT) treatment rather than eye drops, according to an updated NICE guideline published today (Wednesday, 26 January).
Self-harm is everyone's business, NICE says in new draft guideline
All professionals working across the health and social care system have a role to play in supporting people who self-harm and the issue should not just be seen as the responsibility of those with mental health expertise, NICE has said in a new draft guideline.
NICE wants people who show signs of sepsis to be treated with the same urgency given to those with suspected heart attacks.
Thousands with high cholesterol set to benefit from new treatment on the NHS
Thousands of people with high cholesterol will soon have access to a new treatment option on the NHS as a result of final NICE guidance published today (28 April 2021).
Three new treatment options for type 2 diabetes recommended by NICE
Tens of thousands of people with type 2 diabetes will be eligible for new treatments under new guidance from NICE.
Treatment for men with enlarged prostate is recommended by NICE for NHS adoption
Final guidance from NICE recommends the PLASMA system
Triple therapy recommended by NICE for patients with multiple myeloma
The therapy has been recommended after a confidential discount was agreed between NHS England and the drug manufacturer Amgen.